Found: 18
Select item for more details and to access through your institution.
Arachnidism by <italic>Segestria bavarica</italic> with severe neuropathic pain successfully treated with lidocaine 5% plaster.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Effectiveness and safety of lidocaine patch 5% to treat herpes zoster acute neuralgia and to prevent postherpetic neuralgia.
- Published in:
- Dermatologic Therapy, 2021, v. 34, n. 1, p. 1, doi. 10.1111/dth.14590
- By:
- Publication type:
- Article
Sensitization/tolerance profile of betamethasone sodium phosphate in patients with contact allergy to budesonide.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 6, p. 1, doi. 10.1111/dth.14155
- By:
- Publication type:
- Article
Childhood generalized pustular psoriasis: Successful long‐term treatment with adalimumab.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 3, p. 1, doi. 10.1111/dth.13294
- By:
- Publication type:
- Article
A challenging case of contact allergy to corticosteroids: The value of epicutaneous testing not only for etiologic diagnosis but also to prevent severe systemic reactions.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 2, p. e239, doi. 10.1111/jdv.18658
- By:
- Publication type:
- Article
Wireless over‐ear headphones: A new source of allergic contact dermatitis to isothiazolinones.
- Published in:
- Contact Dermatitis (01051873), 2024, v. 90, n. 6, p. 621, doi. 10.1111/cod.14528
- By:
- Publication type:
- Article
Delayed hypersensitivity reactions to iodinated contrast media: A diagnostic approach by skin tests.
- Published in:
- Contact Dermatitis (01051873), 2023, v. 89, n. 5, p. 352, doi. 10.1111/cod.14372
- By:
- Publication type:
- Article
Multiple allergy to cephalosporins confirmed by patch test: From the first to the fifth generation.
- Published in:
- Contact Dermatitis (01051873), 2023, v. 88, n. 6, p. 487, doi. 10.1111/cod.14301
- By:
- Publication type:
- Article
A case of delayed allergy to polyethylene glycol 2000 and polysorbate 80 confirmed by patch test: Consequences for anti‐SARS‐CoV2 vaccination?
- Published in:
- Contact Dermatitis (01051873), 2022, v. 87, n. 2, p. 209, doi. 10.1111/cod.14131
- By:
- Publication type:
- Article
Contact allergy to merbromin: A forgotten organomercuric allergen?
- Published in:
- Contact Dermatitis (01051873), 2022, v. 86, n. 5, p. 439, doi. 10.1111/cod.14060
- By:
- Publication type:
- Article
Contact allergy to hydrocortisone 21‐acetate in Italy: A SIDAPA multicenter study.
- Published in:
- Contact Dermatitis (01051873), 2022, v. 86, n. 3, p. 217, doi. 10.1111/cod.13999
- By:
- Publication type:
- Article
Systemic allergic dermatitis during tetracaine hydrochloride patch testing.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 85, n. 5, p. 596, doi. 10.1111/cod.13921
- By:
- Publication type:
- Article
Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018–2019.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 85, n. 3, p. 317, doi. 10.1111/cod.13873
- By:
- Publication type:
- Article
Patch testing with textile dye mix in Italy: A 2‐year multicenter SIDAPA study.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 4, p. 265, doi. 10.1111/cod.13721
- By:
- Publication type:
- Article
Systemic allergic dermatitis from intra‐articular triamcinolone acetonide: Report of two cases with unusual clinical manifestations.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 1, p. 54, doi. 10.1111/cod.13667
- By:
- Publication type:
- Article
Cross‐reactions to systemic corticosteroids in patients contact sensitized to budesonide.
- Published in:
- Contact Dermatitis (01051873), 2020, v. 83, n. 4, p. 321, doi. 10.1111/cod.13597
- By:
- Publication type:
- Article
Drug‐induced aseptic meningitis to ibuprofen: The first case confirmed by positive patch test.
- Published in:
- Contact Dermatitis (01051873), 2020, v. 82, n. 6, p. 405, doi. 10.1111/cod.13487
- By:
- Publication type:
- Article
Efficacy and safety of upadacitinib in adult patients affected by moderate to severe atopic dermatitis: a 16-week real-life dual-centre experience.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 3, p. 247, doi. 10.1093/ced/llac078
- By:
- Publication type:
- Article